[Treatment of migraine with migristin].
D000293:Adolescent; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D004123:Dimethylamines / Q000009:adverse effects / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use
D004123:Dimethylamines; D010640:Phenothiazines; D010919:Placebos; D013449:Sulfonamides
Leczenie migreny migrystenem.